These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29200751)

  • 21. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual timolol--an alternative to topical medication in glaucoma?
    Sadiq SA; Vernon SA
    Br J Ophthalmol; 1996 Jun; 80(6):532-5. PubMed ID: 8759264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic and clinical studies of pressure-independent damaging factors of open angle glaucoma].
    Araie M
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):213-36; discussion 237. PubMed ID: 21476309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].
    Sugiyama K
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):233-67; discussion 268. PubMed ID: 22568103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing therapeutic paradigms in glaucoma management.
    David R
    Expert Opin Investig Drugs; 1998 Jul; 7(7):1063-86. PubMed ID: 15992016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traumatic Optic Neuropathy (TON) and Ayurveda - A case report.
    Bhat PM
    J Ayurveda Integr Med; 2022; 13(1):100494. PubMed ID: 34844840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
    Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
    Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
    Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study.
    Dandona L; Dandona R; Srinivas M; Mandal P; John RK; McCarty CA; Rao GN
    Ophthalmology; 2000 Sep; 107(9):1702-9. PubMed ID: 10964833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
    Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
    Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
    Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.